| 2024 | Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
| PLOS ONE |
| 2024 | Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2024 | Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2024 | Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007-2021: a nationwide, multicentre, retrospective cohort study
| ECLINICALMEDICINE |
| 2024 | Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities
| GUT AND LIVER |
| 2024 | High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2024 | Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2024 | Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2024 | A Liver Stiffness-Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2024 | Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2024 | Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease | GUT |
| 2024 | Fibrotic Burden in Patients With Hepatitis B Virus-Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes | JOURNAL OF INFECTIOUS DISEASES |
| 2024 | Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2024 | PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B | JOURNAL OF HEPATOLOGY |
| 2023 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature
| JOURNAL OF HEPATOLOGY |
| 2023 | Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2023 | Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
| CELL COMMUNICATION AND SIGNALING |
| 2023 | Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2023 | Utility of fusion imaging for the evaluation of ultrasound quality in hepatocellular carcinoma surveillance
| ULTRASONOGRAPHY |
| 2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Asia-Pacific association for study of liver guidelines on management of ascites in liver disease | HEPATOLOGY INTERNATIONAL |
| 2023 | An international multidisciplinary consensus statement on MAFLD and the risk of CVD
| HEPATOLOGY INTERNATIONAL |
| 2023 | ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus-related liver cirrhosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B | LIVER INTERNATIONAL |
| 2023 | Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
| GUT AND LIVER |
| 2023 | Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2023 | Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study
| CANCERS |
| 2023 | The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia study | JOURNAL OF VIRAL HEPATITIS |
| 2023 | Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: A DALY-based analysis of the Global Burden of Disease 2019 study
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
| 2023 | Age, Sex, and Body Mass Index Should Be Considered When Assessing Spleen Length in Patients with Compensated Advanced Chronic Liver Disease
| GUT AND LIVER |
| 2023 | Preface
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | CAGE-B and SAGE-B models better predict the hepatitis B virus-related hepatocellular carcinoma after 5-year entecavir treatment than PAGE-B | JOURNAL OF DIGESTIVE DISEASES |
| 2023 | Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2023 | Ideal cardiovascular health metrics and the risk of nonalcoholic fatty liver disease in Korean adults
| Clinical Hypertension |
| 2023 | Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
| FRONTIERS IN ENDOCRINOLOGY |
| 2023 | Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
| DIAGNOSTICS |
| 2023 | Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
| HEPATOLOGY COMMUNICATIONS |
| 2023 | Self-Management and Associated Factors among Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study
| INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH |
| 2023 | Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Dise | GUT AND LIVER |
| 2022 | Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population | HEPATOLOGY INTERNATIONAL |
| 2022 | Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B | LIVER INTERNATIONAL |
| 2022 | Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease | ABDOMINAL RADIOLOGY |
| 2022 | 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
| CLINICAL AND MOLECULAR HEPATOLOGY |
http://orcid.org/0000-0002-9658-8050
(54933821200)
